Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
8,021
+1,386
+21% +$162K 0.27% 95
2026
Q1
$798K Buy
6,635
+372
+6% +$42.9K 0.23% 105
2025
Q4
$659K Buy
6,263
+50
+0.8% +$4.69K 0.19% 118
2025
Q3
$521K Sell
6,213
-9,187
-60% -$757K 0.16% 123
2025
Q2
$1.22M Buy
+15,400
New +$1.22M 0.41% 77

Other funds holding MRK

LOM Asset Management's MRK Position: Q2 2026 in Review

LOM Asset Management increased its Merck (MRK) stake by 21% in Q2 2026, buying an estimated $162K and bringing the position to 8,021 shares worth $1.03M. The position accounts for 0.27% of the portfolio, ranked #95.

LOM Asset Management first reported a position in MRK in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.22M in Q2 2025. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • LOM Asset Management held 8,021 shares of Merck worth $1.03M as of Q2 2026.
  • LOM Asset Management bought 1,386 Merck shares in Q2 2026, an estimated $162K.
  • Merck made up 0.27% of LOM Asset Management's portfolio in Q2 2026, its #95 holding.
  • LOM Asset Management first reported a position in Merck in Q2 2025 and has held it in 5 quarters since.
  • LOM Asset Management's Merck position peaked at $1.22M in Q2 2025.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on LOM Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.